masitinib

Levine Keszler is advising AB Science on European Investment Bank funding to support the clinical development programme evaluating masitinib in the treatment of Covid-19. Aude Manzo-KeszlerPierre TreilleFinancingHealthGeneral
8 December 2020

Levine Keszler is advising AB Science on European Investment Bank funding to support the clinical development programme evaluating masitinib in the treatment of Covid-19.

Après une première étape de transmission capitalistique au Management, soutenue par UI Gestion, en 2017,…
Serge Levine